Maternal serum inhibin-A in pregnancies with insulin-dependant diabetes mellitus: Implications for screening for Down's syndrome

Prenatal Diagnosis

Volumn 16, Issue 10, 1996, Pages 923-926

  Wald, N J ^a   Watt, H C ^a   George, L ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

Down's syndrome; Inhibin A; Insulin dependent diabetes mellitus; Maternal serum screening

Indexed keywords

INHIBIN; MARKER;

ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DOWN SYNDROME; FEMALE; GESTATIONAL AGE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MATERNAL SERUM; PRENATAL DIAGNOSIS; PRENATAL SCREENING; PRIORITY JOURNAL; STORAGE;

ALPHA-FETOPROTEINS; CHORIONIC GONADOTROPIN; DIABETES MELLITUS, TYPE 1; DOWN SYNDROME; ESTRIOL; FEMALE; HUMANS; INHIBINS; PREGNANCY; PREGNANCY IN DIABETICS; PRENATAL DIAGNOSIS; REFERENCE VALUES;

EID: 0029797558     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0223(199610)16:10<923::AID-PD970>3.0.CO;2-A     Document Type: Article

References (21)

1. Baird, D.T., Smith, K.B. (1993). Inhibin and related peptides in the regulation of reproduction, Oxford Rev. Reprod. Biol, 15, 191-232.
2. Canick, J.A., Lambert-Messerlian, G.M., Palomaki, G.E., Schneyer, A.L., Tumber, M.B., Knight, G.J., Haddow, J.E. (1994). Maternal serum dimeric inhibin is elevated in Down syndrome pregnancy. Am. J. Hum. Genet., 55, A37.
3. Cuckle, H.S., Wald, N.J. (1990). Screening for Down's syndrome. In: Lilford, R.J. (Ed.). Prenatal Diagnosis and Prognosis, Butterworths, 67-92.
4. Cuckle, H.S., Holding, S., Jones, R., Wallace, E.M., Groome, N.P. (1995). Maternal serum dimeric inhibin A in second-trimester Down's syndrome pregnancies, Prenat. Diagn., 15, 385-392.
5. Greene, M.F., Haddow, J.E., Palomaki, G.E., Knight, G.J. (1988). Maternal serum alpha-fetoprotein levels in diabetic pregnancies, Lancet, ii, 345-346.
6. Groome, N.P., Illingworth, P.J., O'Brian, M., Cooke, I., Ganesan, T.S., McNeilly, A.S. (1994). Detection of dimeric inhibin throughout the human menstrual cycle by two-site enzyme immunoassay, Clin. Endocrinol., 40, 717-723.
7. McLachlan, R.I., Healy, D.L., Lutjen, P.J., Findlay, J.K., de Kretser, D.M., Burger, H.G. (1987a). The maternal ovary is not the source of circulating inhibin levels during human pregnancy, Clin. Endocrinol., 27, 663-668.
8. McLachlan, R.I., Healy, D.L., Robertson, D.M., Burger, H.G., de Kretser, D.M. (1987b). Circulating immunoreactive inhibin in the luteal phase and early gestation in women undergoing ovulation induction. Fertil Steril., 48, 1011-1015.
9. Milunsky, A., Alpert, E., Kitzmiller, J.L., Younger, M.D., Neff, R.K. (1982). Prenatal diagnosis of neural tube defects. VIII. The importance of serum alpha-fetoprotein screening in diabetic pregnant women, Am. J. Obstet. Gynecol, 142, 1030-1032.
10. Muttukrishna, S., Fowler, P.A., Groome, N.P., Mitchell, G.G., Robertson, W.R., Knight, P.G. (1994). Serum concentrations of dimeric inhibin during the spontaneous human menstrual cycle and after treatment with exogenous gonadotrophin, Hum. Reprod., 9, 1634-1642.
11. A dimer) during human pregnancy, J. Clin. Endocrino., 42, 391-397.
12. Petraglia, F., Sawchenko, P., Lim, A.T.W., Rivier, J., Vale, W. (1987). Localization, secretion, and action of inhibin in human placenta, Science, 237, 187-189.
13. Reece, E.A., Davis, N., Mahoney, M.J., Baugarten, A. (1987). Maternal serum alpha-fetoprotein in diabetic pregnancy: correlation with blood glucose control, Lancet, ii, 275.
14. Wald, N.J., Cuckle, H., Boreham, J., Stirrat, G.M., Turnbull, A.C. (1979). Maternal serum alphafetoprotein and diabetes mellitus. Br. J. Obstet. Gynaecol., 86, 101-105.
15. Wald, N.J., Cuckle, H.S., Densem, J.W., Stone, R.B. (1992). Maternal serum unconjugated oestriol and human chorionic gonadotrophin levels in pregnancies with insulin-dependent diabetes: implications for screening for Down's syndrome, Br. J. Obstet. Gynaecol., 99, 51-53.
16. Wald, N.J., Densem, J.W., Cheng, R., Collishaw, S. (1994). Maternal serum free α- and free β-human chorionic gonadotrophin in pregnancies with insulin-dependent diabetes mellitus: implications for screening for Down's syndrome, Prenat. Diagn., 14, 835-837.
17. Wald, N.J., Densem, J.W., George, L., Muttukrishna, S., Knight, P.G. (1996). Prenatal screening for Down's syndrome using inhibin-A as a serum marker, Prenat. Diagn., 16, 143-153.
18. Wallace, E.M., Grant, V.E., Swanston, I.A., McNeilly, A.S., Blundell, G., Ashby, H.P., Groome, N.P. (1995). Second trimester screening for Down's syndrome using inhibin-A, J. Endocrinol, 144, 134.
19. Watt, H.C., Wald, N.J., Smith, D., Kennard, A., Densem, J. (1996). Effect of allowing for ethnic group in antenatal screening for Down's syndrome, Prenat. Diagn., 16, 691-698.
20. Webley, G., Muttukrishna, S., Groome, N.P., Knight, P.G. (1994). Evidence that endogenous dimeric inhibin enhances progesterone production by human granulosa-lutein cells, J. Reprod. Fertil. Abstr. Ser., 13, 85A.
21. Ying, S.Y. (1988). Inhibins, activins and follistatins: gonadal proteins modulating the secretion of follicle-stimulating hormone, Endocrine Rev., 9, 267-293.